Talphera (TLPH) Accounts Payables (2010 - 2026)
Talphera's (TLPH) quarterly Accounts Payables came in at $927000.0 in Q1 2026, up 184.36% year-on-year from $326000.0 in Q1 2025, and up 70.4% quarter-over-quarter from $544000.0 in Q4 2025.
Talphera (TLPH) Accounts Payables (2010 - 2026) Analysis & Trends
Talphera's Accounts Payables history runs 17 years deep, the most recent figure standing at $927000.0 for Q1 2026.
- On a quarterly basis, Accounts Payables rose 184.36% year-over-year to $927000.0 in Q1 2026; TTM through Mar 2026 was $927000.0, a 184.36% increase from a year earlier, with the FY2025 full-year figure at $544000.0, down 18.81% from the prior year.
- Accounts Payables grew to $927000.0 in Q1 2026 per TLPH's latest filing, from $544000.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $2.7 million in Q1 2022 and bottomed at $326000.0 in Q1 2025.
- The 5-year median for Accounts Payables is $1.0 million (2023), against an average of $1.2 million.
- Across the five-year window, Accounts Payables slumped 74.41% in 2025 and jumped 184.36% in 2026, its largest moves.
- Year by year, Accounts Payables stood at $1.3 million in 2022, then rose by 6.37% to $1.3 million in 2023, then tumbled by 49.85% to $670000.0 in 2024, then decreased by 18.81% to $544000.0 in 2025, then jumped by 70.4% to $927000.0 in 2026.
- Per Business Quant, the three latest TLPH Accounts Payables figures stand at $927000.0 (Q1 2026), $544000.0 (Q4 2025), and $526000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | 927,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 927,000.00 |
| Dec 31, 2025 | 544,000.00 |
| Sep 30, 2025 | 526,000.00 |
| Jun 30, 2025 | 835,000.00 |
| Mar 31, 2025 | 326,000.00 |
| Dec 31, 2024 | 670,000.00 |
| Sep 30, 2024 | 396,000.00 |
| Jun 30, 2024 | 808,000.00 |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | 1.34 Mn |
| Sep 30, 2023 | 1.03 Mn |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 1.40 Mn |
| Dec 31, 2022 | 1.26 Mn |
| Sep 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 2.40 Mn |
| Mar 31, 2022 | 2.72 Mn |
| Dec 31, 2021 | 2.12 Mn |
| Sep 30, 2021 | 2.23 Mn |
| Jun 30, 2021 | 1.94 Mn |